Total Payments
$1,292
2024 Payments
$204.95
Companies
20
Transactions
47
Medicare Patients
1,340
Medicare Billing
$97,540
Payment Breakdown by Category
Food & Beverage$1,242 (96.1%)
Consulting$36.17 (2.8%)
Education$14.08 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,242 | 45 | 96.1% |
| Consulting Fee | $36.17 | 1 | 2.8% |
| Education | $14.08 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $254.83 | 5 | $0 (2024) |
| Gilead Sciences, Inc. | $203.72 | 9 | $0 (2024) |
| PFIZER INC. | $142.23 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $74.40 | 3 | $0 (2024) |
| Exact Sciences Corporation | $63.39 | 3 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $61.22 | 1 | $0 (2017) |
| Arbor Pharmaceuticals, Inc. | $60.75 | 1 | $0 (2017) |
| BioDelivery Sciences International, Inc. | $60.75 | 1 | $0 (2017) |
| Purdue Pharma L.P. | $59.81 | 1 | $0 (2017) |
| Lilly USA, LLC | $48.10 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $204.95 | 10 | Regeneron Healthcare Solutions, Inc. ($74.40) |
| 2023 | $138.35 | 5 | Gilead Sciences, Inc. ($54.74) |
| 2022 | $189.68 | 6 | Novo Nordisk Inc ($129.05) |
| 2021 | $145.71 | 7 | Gilead Sciences, Inc. ($63.52) |
| 2020 | $110.97 | 6 | Gilead Sciences, Inc. ($62.35) |
| 2018 | $131.03 | 4 | Novo Nordisk Inc ($88.24) |
| 2017 | $371.78 | 9 | PFIZER INC. ($63.21) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: DERMATOLOGY | ||||||
| 10/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.11 | General |
| 09/25/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Oncology | ||||||
| 06/27/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 03/27/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 02/05/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 01/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Diabetes | ||||||
| 11/07/2023 | Baxter Healthcare | — | Food and Beverage | In-kind items and services | $43.88 | General |
| 05/10/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Oncology | ||||||
| 03/29/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.70 | General |
| 03/28/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: HCV | ||||||
| 01/19/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Oncology | ||||||
| 09/15/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Diabetes | ||||||
| 07/14/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Gastroenterology | ||||||
| 06/22/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Diabetes | ||||||
| 05/12/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $112.41 | General |
| Category: Diabetes | ||||||
| 02/16/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Gastroenterology | ||||||
| 01/31/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Diabetes | ||||||
| 11/10/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Diabetes | ||||||
| 10/21/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.16 | General |
| 09/30/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.41 | General |
| 09/14/2021 | Itamar Medical Inc | WatchPAT (Device) | Consulting Fee | Cash or cash equivalent | $36.17 | General |
| Category: Sleep Apnea testing | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 205 | 325 | $39,705 | $13,469 |
| 2022 | 14 | 296 | 519 | $53,720 | $18,903 |
| 2021 | 14 | 483 | 811 | $80,445 | $32,773 |
| 2020 | 11 | 356 | 723 | $85,605 | $32,396 |
Total Patients
1,340
Total Services
2,378
Medicare Billing
$97,540
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 78 | $14,400 | $4,616 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 44 | $12,580 | $3,266 | 26.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 24 | 24 | $5,640 | $2,970 | 52.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 22 | $2,035 | $1,081 | 53.1% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 16 | 50 | $1,420 | $614.09 | 43.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 31 | 40 | $1,580 | $380.80 | 24.1% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 17 | 17 | $750.00 | $265.20 | 35.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 16 | $960.00 | $160.02 | 16.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 29 | 34 | $340.00 | $115.94 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 91 | $17,800 | $5,338 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 54 | $15,170 | $4,432 | 29.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 32 | 94 | $7,990 | $3,933 | 49.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 22 | 22 | $5,170 | $2,868 | 55.5% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 15 | 53 | $1,590 | $659.63 | 41.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 26 | 36 | $1,305 | $346.38 | 26.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 18 | 19 | $1,065 | $316.99 | 29.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 18 | 20 | $700.00 | $265.81 | 38.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 22 | 24 | $720.00 | $251.83 | 35.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 21 | 21 | $570.00 | $162.21 | 28.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 14 | $825.00 | $102.65 | 12.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 23 | 31 | $530.00 | $92.55 | 17.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 11 | 23 | $115.00 | $74.56 | 64.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 14 | 17 | $170.00 | $58.30 | 34.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 55 | 157 | $34,680 | $13,744 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 44 | 44 | $10,340 | $5,856 | 56.6% |
About Dr. Gregory Smith, MD
Dr. Gregory Smith, MD is a Family Medicine healthcare provider based in Lilburn, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861582934.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Smith, MD has received a total of $1,292 in payments from pharmaceutical and medical device companies, with $204.95 received in 2024. These payments were reported across 47 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,242).
As a Medicare-enrolled provider, Smith has provided services to 1,340 Medicare beneficiaries, totaling 2,378 services with total Medicare billing of $97,540. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lilburn, GA
- Active Since 10/12/2006
- Last Updated 12/15/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1861582934
Products in Payments
- Ozempic (Drug) $233.16
- EUCRISA (Drug) $80.70
- EVKEEZA (Biological) $74.40
- Cologuard Collection Kit (Device) $63.39
- RELISTOR (Drug) $61.22
- BELBUCA (Drug) $60.75
- Horizant (Drug) $60.75
- WatchPAT (Device) $36.17
- JARDIANCE (Drug) $34.80
- XIFAXAN (Drug) $25.16
- Epclusa (Drug) $25.04
- JANUVIA (Drug) $23.42
- RYBELSUS (Drug) $21.67
- VYNDAQEL (Drug) $21.55
- ENTRESTO (Drug) $20.77
- HUMALOG (Drug) $19.04
- TRULANCE (Drug) $18.13
- UBRELVY (Drug) $16.67
- TRULICITY (Drug) $16.12
- ZORYVE (Drug) $15.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lilburn
Dr. Glenn Heigerick, Do, DO
Family Medicine — Payments: $247,141
Family Medicine $247,141
Dr. Inder Singh, M.d, M.D
Family Medicine — Payments: $8,391
Family Medicine $8,391
Aziz Pirani, Md, MD
Family Medicine — Payments: $8,287
Family Medicine $8,287
Changchun Wu, Md, MD
Family Medicine — Payments: $6,867
Family Medicine $6,867
Dr. Scott Keller, Do, DO
Family Medicine — Payments: $3,315
Family Medicine $3,315
Dr. Robert Frantz, D.o, D.O
Family Medicine — Payments: $1,550
Family Medicine $1,550